Abstract: The disclosure is a medical device system that applies pressure to biologic products in a container to inactivate pathogens (e.g., viruses, bacteria, including sepsis, fungi, parasites, prions, mold and other harmful microorganisms), or abnormal or damaged cells (e.g., cancer, carcinoma in situ, lipoproteins, lipids, antibodies), while preserving the desired cells and the efficacy of the biologic product (e.g., whole blood, plasma, red blood cells, platelets and cells derived from blood, bone marrow, stem cells, brain dura matter, bone graft, skin graft or other bodily sources, either allogeneic or autologous). The biologic product may be autologously sourced then processed and transfused or administered, or be allogeneicly sourced and then processed and transfused or administered.

Abstract: A medical implant device includes a shaft, an expandable member coupled to the distal end portion of the shaft, a sleeve and a detachment mechanism. The expandable member is configured to move between a collapsed configuration and an expanded configuration, and can be used to deliver a medicament, a therapeutic substance and/or a structural member into the body. The sleeve is coupled to the distal end portion of the shaft, and is configured to move relative to the shaft between a first position and a second position. The sleeve is configured to be disposed about the expandable member when in the first position and disposed apart from the expandable member when in the second position. The detachment mechanism is coupled to the distal end portion of the shaft, and is configured to detach the expandable member from the shaft when the sleeve is in the second position.